Cardio Diagnostics (CDIOW) to Release Quarterly Earnings on Wednesday

Cardio Diagnostics (NASDAQ:CDIOW) is expected to be releasing its results before the market opens on Wednesday, February 25th. Analysts expect Cardio Diagnostics to post earnings of ($1.80) per share and revenue of $0.25 million for the quarter.

Cardio Diagnostics Stock Performance

NASDAQ:CDIOW opened at $0.02 on Friday. Cardio Diagnostics has a one year low of $0.01 and a one year high of $0.09. The business has a fifty day moving average price of $0.02 and a 200-day moving average price of $0.02.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.